Novacyt Group Microgen Bioproducts™ SARS-CoV-2 IgG EIA
For the screening of patients previously infected, to either; confirm infection, monitor the course of disease, or to draw epidemiological conclusions. Includes all additional reagents required to perform each test.
Additional Details:
Weight:
0.60000kg
Specification
Calibration | Standard ELISA calibration format - Pos/neg controls included with the kit |
---|---|
Certifications/Compliance | CE IVD certified, DoC Documentation |
Content And Storage | 2°C to 8°C |
Control Sets | Both positive and negative controls |
CE Marker | Yes |
Detectable Analytes | SARS-CoV-2 IgG Antibodies (Nucleocapsid Protein) |
Detection Method | Enzyme-linked immunosorbent assay; chromatography/colour change |
Format | 96-well Plate |
Sample Type | Human Plasma or Human Serum |
Sensitivity | 100% - > 14 days post PCR confirmation |
Type | Antibody ELISA |
Formulation | Chemical compositions are found in Safety Data Sheets |
For Use With (Application) | ELISA |
For Use With (Equipment) | Manual OR Automated ELISA Systems & Plate Reader for Interpretation |
Includes | Positive control 1 x 3.5 mL, Negative control 1 x 3.5 mL, Wash buffer 2 x 12 5 mL, Sample buffer 2 x 125 mL, Conjugate 1 x 60 mL, Substrate solution 1 x 60 mL, Stop solution 1 x 60 mL |
Material | Polypropylene Plates |
No. of Reactions | 480 |
Organism Group | Antibodies |
Packaging Type | Foil pouches and plastic bottles |
Quantity | 15/Pk. |
Sample Size | 5 μL of human plasma or human serum |
Species | Human |
Specificity | 0.994 |
Sterility | Sterile |
Target Organism Class | Antibodies/Nucleocapsid protein |
Test Time | <1.5 hr. |